• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性前列腺切除标本中的雄激素受体、Ki67和p53表达可预测日本人群的治疗失败情况。

Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population.

作者信息

Inoue Takahiro, Segawa Takehiko, Shiraishi Taizou, Yoshida Toru, Toda Yoshinobu, Yamada Tomomi, Kinukawa Naoko, Kinoshita Hidefumi, Kamoto Toshiyuki, Ogawa Osamu

机构信息

Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

出版信息

Urology. 2005 Aug;66(2):332-7. doi: 10.1016/j.urology.2005.02.028.

DOI:10.1016/j.urology.2005.02.028
PMID:16098362
Abstract

OBJECTIVES

To evaluate multiple known prognostic markers in localized prostate cancer using tissue microarrays in Japanese patients. Molecular studies have suggested that ethnicity influences prostate tumor biology.

METHODS

Specimens were studied from 52 patients who underwent radical surgery at our institution between 1997 and 2001 without neoadjuvant hormonal therapy and with three or more available and complete cancer spots. Ki67, p53, and androgen receptor antigen expression were examined. Immunohistochemical scores were compared with outcomes of chemical relapse as monitored using prostate-specific antigen.

RESULTS

Pathologic tumor classification (P = 0.047), World Health Organization score (P = 0.026), World Health Organization histologic grade (P = 0.026), and surgical margin status (P = 0.018) were significant conventional clinicopathologic variables for predicting biochemical failure. The tissue microarray Gleason sum (P = 0.038), tissue microarray primary Gleason grade (P = 0.013), Ki67 labeling index (P < 0.0001), p53 (P = 0.0097), and androgen receptor (P = 0.0113) antigen expression also were significant. Moreover, surgical margin status and Ki67 labeling index were independently associated with treatment failure.

CONCLUSIONS

Especially together, the Ki67 labeling index and p53 and androgen receptor expression in localized prostate cancer often predicted postoperative progression in Japanese patients.

摘要

目的

利用组织芯片评估日本局部前列腺癌患者的多种已知预后标志物。分子研究表明,种族会影响前列腺肿瘤生物学特性。

方法

对1997年至2001年间在本院接受根治性手术、未接受新辅助激素治疗且有三个或更多可用且完整癌灶的52例患者的标本进行研究。检测Ki67、p53和雄激素受体抗原表达。将免疫组织化学评分与使用前列腺特异性抗原监测的生化复发结果进行比较。

结果

病理肿瘤分类(P = 0.047)、世界卫生组织评分(P = 0.026)、世界卫生组织组织学分级(P = 0.026)和手术切缘状态(P = 0.018)是预测生化失败的重要传统临床病理变量。组织芯片Gleason总分(P = 0.038)、组织芯片主要Gleason分级(P = 0.013)、Ki67标记指数(P < 0.0001)、p53(P = 0.0097)和雄激素受体(P = 0.0113)抗原表达也具有显著性。此外,手术切缘状态和Ki67标记指数与治疗失败独立相关。

结论

特别是联合起来,局部前列腺癌中的Ki67标记指数以及p53和雄激素受体表达常常可预测日本患者术后的病情进展。

相似文献

1
Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population.根治性前列腺切除标本中的雄激素受体、Ki67和p53表达可预测日本人群的治疗失败情况。
Urology. 2005 Aug;66(2):332-7. doi: 10.1016/j.urology.2005.02.028.
2
Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men.Akt及磷酸化Akt表达增加与日本男性前列腺癌的恶性生物学特征相关。
BJU Int. 2007 Sep;100(3):685-90. doi: 10.1111/j.1464-410X.2007.07014.x. Epub 2007 Jun 2.
3
p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy.p53蛋白过表达与局部复发性前列腺癌患者放疗后细胞增殖增加有关。
Cancer. 1999 Mar 15;85(6):1293-9.
4
[Prognostic factors of prostate cancer: usefulness of Ki-67 expression in preoperative biopsies].[前列腺癌的预后因素:Ki-67表达在术前活检中的应用价值]
Arch Esp Urol. 2004 Oct;57(8):805-16.
5
Utility of Bcl-2, P53, Ki-67, and caveolin-1 immunostaining in the prediction of biochemical failure after radical prostatectomy in a Japanese population.Bcl-2、P53、Ki-67和小窝蛋白-1免疫染色在日本人群根治性前列腺切除术后生化复发预测中的应用
Urology. 2008 Jul;72(1):167-71. doi: 10.1016/j.urology.2007.11.003. Epub 2008 Apr 2.
6
Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer.组织芯片分析揭示了syndecan-1表达在前列腺癌中的预后意义。
Prostate. 2003 Apr 1;55(1):20-9. doi: 10.1002/pros.10209.
7
Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy.Ki-67、细胞周期蛋白D1的表达以及凋亡标志物与接受根治性前列腺切除术治疗的前列腺癌患者的生存率相关。
Anticancer Res. 2006 Nov-Dec;26(6C):4873-8.
8
Expression of clusterin in prostate cancer correlates with Gleason score but not with prognosis in patients undergoing radical prostatectomy without neoadjuvant hormonal therapy.在未接受新辅助激素治疗的接受根治性前列腺切除术的患者中,簇集素在前列腺癌中的表达与 Gleason 评分相关,但与预后无关。
Urology. 2006 Sep;68(3):609-14. doi: 10.1016/j.urology.2006.03.017. Epub 2006 Sep 18.
9
Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.雄激素受体信使核糖核酸表达的肿瘤与良性比例较高与根治性前列腺切除术后前列腺癌进展相关。
Urology. 2007 Dec;70(6):1225-9. doi: 10.1016/j.urology.2007.09.010.
10
Prognostic significance of Bcl-2 in clinically localized prostate cancer.Bcl-2在临床局限性前列腺癌中的预后意义。
Am J Pathol. 1996 May;148(5):1557-65.

引用本文的文献

1
The Emerging Predictive and Prognostic Role of Aggressive-Variant-Associated Tumor Suppressor Genes Across Prostate Cancer Stages.侵袭性变异相关肿瘤抑制基因在前列腺癌各阶段新兴的预测和预后作用。
Int J Mol Sci. 2025 Jan 1;26(1):318. doi: 10.3390/ijms26010318.
2
Newly developed preclinical models reveal broad-spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamide.新开发的临床前模型显示,广谱 CDK 抑制剂是一种有效的药物,可用于对恩杂鲁胺表现出原发性耐药的 CRPC。
Cancer Sci. 2024 Jan;115(1):283-297. doi: 10.1111/cas.15984. Epub 2023 Nov 3.
3
Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy.
单中心评估 Ki-67 标记指数联合改良 RPA 评分作为 IDH 野生型胶质母细胞瘤患者接受放化疗后生存的预后因素。
Strahlenther Onkol. 2022 Oct;198(10):892-906. doi: 10.1007/s00066-022-01959-6. Epub 2022 May 25.
4
Assessment of biochemical recurrence of prostate cancer (Review).前列腺癌生化复发的评估(综述)。
Int J Oncol. 2019 Dec;55(6):1194-1212. doi: 10.3892/ijo.2019.4893. Epub 2019 Oct 4.
5
The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the Literature.免疫组织化学分析作为前列腺癌诊断、预后评估和治疗工具的作用:文献系统综述
Front Oncol. 2018 Sep 18;8:377. doi: 10.3389/fonc.2018.00377. eCollection 2018.
6
Effects of concentrated long-chain omega-3 polyunsaturated fatty acid supplementation before radical prostatectomy on prostate cancer proliferation, inflammation, and quality of life: study protocol for a phase IIb, randomized, double-blind, placebo-controlled trial.根治性前列腺切除术前行集中长链ω-3 多不饱和脂肪酸补充对前列腺癌增殖、炎症和生活质量的影响:一项 IIb 期、随机、双盲、安慰剂对照试验的研究方案。
BMC Cancer. 2018 Jan 10;18(1):64. doi: 10.1186/s12885-017-3979-9.
7
Androgen Receptor Expression in Epithelial and Stromal Cells of Prostatic Carcinoma and Benign Prostatic Hyperplasia.雄激素受体在前列腺癌和良性前列腺增生上皮及基质细胞中的表达
Open Access Maced J Med Sci. 2017 Aug 5;5(5):608-612. doi: 10.3889/oamjms.2017.151. eCollection 2017 Aug 15.
8
Stromal Androgen Receptor in Prostate Cancer Development and Progression.基质雄激素受体在前列腺癌发生发展中的作用
Cancers (Basel). 2017 Jan 22;9(1):10. doi: 10.3390/cancers9010010.
9
Androgen receptor phosphorylation status at serine 578 predicts poor outcome in prostate cancer patients.雄激素受体丝氨酸578位点的磷酸化状态可预测前列腺癌患者的不良预后。
Oncotarget. 2017 Jan 17;8(3):4875-4887. doi: 10.18632/oncotarget.13608.
10
Quantitative Time-Resolved Fluorescence Imaging of Androgen Receptor and Prostate-Specific Antigen in Prostate Tissue Sections.前列腺组织切片中雄激素受体和前列腺特异性抗原的定量时间分辨荧光成像
J Histochem Cytochem. 2016 May;64(5):311-22. doi: 10.1369/0022155416640466. Epub 2016 Mar 29.